🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Jefferies Group’s IRON Holdings & Trades

First Buy
Q3 2026
Duration Held
1 Quarters
Largest Add
Q3 2026
+10,795 Shares
Current Position
10,795 Shares
$706,641 Value

Jefferies Group's IRON Position Overview

Jefferies Group (via Jefferies Financial Group Inc.) currently holds 10,795 shares of Disc Medicine, Inc. (IRON) worth $706,641, representing 0.01% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.

Based on recent 13F filings, Jefferies Group has initiated a new position in IRON, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.

Analysis based on 13F filings available since 2013 Q2

Jefferies Group's Disc Medicine (IRON) Holding Value Over Time

Track share changes against reported price movement

Quarterly Disc Medicine (IRON) Trades by Jefferies Group

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +10,795 New Buy 10,795 $65.46

Jefferies Group's Disc Medicine Investment FAQs

Jefferies Group first purchased Disc Medicine, Inc. (IRON) in Q3 2026, acquiring 10,795 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Jefferies Group has held Disc Medicine, Inc. (IRON) for 1 quarters since Q3 2026.

Jefferies Group's largest addition to Disc Medicine, Inc. (IRON) was in Q3 2026, adding 10,795 shares worth $706,641.

According to the latest 13F filing for Q3 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 10,795 shares of Disc Medicine, Inc. (IRON), valued at approximately $706,641.

As of the Q3 2026 filing, Disc Medicine, Inc. (IRON) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.

Jefferies Group's peak holding in Disc Medicine, Inc. (IRON) was 10,795 shares, as reported at the end of Q3 2026.